These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

In addition to using gemcitabine and the natural killer cells that are TGF-β imprinted, we also are combining an anti-GD2 antibody called naxitamab that's provided by Y-mAbs. Naxitamab, as I said, is ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...

A battery that needs feeding instead of charging? This is exactly what Empa researchers have achieved with their 3D-printed, ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

NK Cells Expressing Interleukin-21 Show Promising Antitumor Activity in Glioblastoma Cells Aug. 12, 2024 — Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated ...

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

D cell cultures are reshaping and redefining the way medical professionals treat patients. Learn a few interesting facts ...